drugset / Trial / NCT01715233
Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.
NaSingle-groupOpen-labelTreatment
Summary
To estimate and compare the response rates in patients treated with mDCF based on methylation status of CHFR.
Timeline
- Start
- 2012-12
- Primary completion
- 2015-06
- Completion
- 2017-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | 40 mg/m2 | — |
| Subject | Cisplatin | Other / unclassified | 40 mg/m2 | — |
| Subject | Docetaxel | Small molecule | 40 mg/m2 | — |
| Subject | Leucovorin | Small molecule | 400 mg/m2 | — |
| Subject | fluorouracil | Small molecule | 400 mg/m2 | — |
| Subject | fluorouracil | Small molecule | 1000 mg/m2 | — |